Next Article in Journal
Peptides Incorporating 3,4-Dihydroxyprolines: Synthesis and Structural Study
Previous Article in Journal
Comparative Investigation of Membrane Systems for Crystallization and Spherical Agglomeration
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

X-ray Diffraction Study of Fluorine-Functionalized Thiosemicarbazones and Cyclometallated Compounds †

Department of Inorganic Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Avda. das Ciencias s/n, 15782 Santiago de Compostela, Spain
*
Author to whom correspondence should be addressed.
Presented at the 3rd International Online Conference on Crystals, 15–30 January 2022; Available online: https://iocc_2022.sciforum.net/.
Chem. Proc. 2022, 9(1), 3; https://doi.org/10.3390/IOCC_2022-12140
Published: 12 January 2022
(This article belongs to the Proceedings of The 3rd International Online Conference on Crystals)

Abstract

:
In this work, an X-ray diffraction study of fluorine-functionalized thiosemicarbazone ligands and their corresponding cyclometallated compounds is discussed. The results are in agreement with previous characterization by IR spectroscopy, 1H and 19F NMR spectroscopy. Suitable crystals were obtained for a thiosemicarbazone ligand and a cyclometallated compound. The crystal structure analyses are in accordance with the proposed structures: a fluorine-functionalized thiosemicarbazone ligand and a cyclometallated compound in which the thiosemicarbazone is a tridentate [C, N, S] ligand. A comparative study of bond distances and angles is shown, providing information about the coordination of the ligand to the metal center.

1. Introduction

In this work, fluorine-thiosemicarbazone ligands were used to synthesize cyclometallated palladium compounds. The fluorine functionality increases their solubility, which is one of the main issues when dealing with this type of species [1,2].
The ligands are widely used in coordination and organometallic chemistry due to the number of different heteroatoms and their versatile coordination to metal centers [3], generating a wide range of compounds. In addition, these ligands are relevant in the biological field; the free ligands themselves possess a certain degree of biological activity [4,5], usually enhanced by coordination to one or more metal atoms [6,7].
Furthermore, cyclometallated compounds are a large family of complexes that contain a chelate ring comprising a coordinated heteroatom–metal bond or a σ carbon–metal bond [8,9]. The metalated atom may be an aromatic [10,11] or alkenyl [12] sp2 carbon or an sp3 carbon [13]. Many of these compounds are used in catalysis, and they produce very good results in cross-coupling reactions with carbon–carbon bond formation (Suzuki–Miyaura [14,15] and Mizoroki–Heck [16,17]) and carbon–nitrogen bond formation (Buchwald–Hartwig [18,19]). Likewise, their biological activity has been shown to be quite high, and it has been tested for a huge variety of metals and ligands [20,21,22,23].

2. Results and Discussion

An X-ray diffraction study of a thiosemicarbazone ligand and the ensuing palladium cyclometallated product is discussed (see Scheme 1). The results agree with a previous characterization by IR, 1H NMR and 19F NMR spectroscopies [24]. In addition, a structural study and comparison between the two structures were carried out.

2.1. X-ray Diffraction Study

Suitable crystals for compounds were obtained by slow evaporation of a DMSO−acetone (3a) or chloroform (4b) solution, shown in Scheme 2. The X-ray diffraction study showed the proposed structures. The structures were solved by direct methods and refined by full-matrix least-squares on F2. Hydrogen atoms were included in calculated positions. Refinement converged at a final R1 = 0.0302 and wR2 = 0.0712 (compound 3a) and R1 = 0.0299 and wR2 = 0.0625 (compound 4b) with allowance for thermal anisotropy of all non-hydrogen atoms. The structure solution and refinement were carried out using the program OLEX2 [25].

2.1.1. Compound 3a

Compound 3a crystallizes in a monoclinic system, P21/n space group. The unit cell contains four molecules of thiosemicarbazone (see Figure 1). Crystal data is shown in Appendix A (Table A1).
The structure shows thiosemicarbazone in the thionic form, with E conformation [26], probably due to the intramolecular interaction (2.179 Å) between the imine nitrogen and the thioamide proton, shown in Figure 2a.
In addition, intramolecular interaction (2.378 Å) between the fluorine atom and the imine methyl group is observed. Consequently, in Figure 2b, the aromatic ring is turned away from the thiosemicarbazone plane, with a 34.34° deviation.

2.1.2. Compound 4b

Compound 4b crystallizes in a triclinic system, P-1 space group. The unit cell contains two cyclometallated molecules and eight chloroform molecules. Crystal data is shown in Appendix A (Table A2).
The thiosemicarbazone acts as a tridentate ligand (see Figure 3a), generating two five-membered chelate rings, and the compound shows a tetranuclear structure in Figure 3b, with the ligands assuming an antiparallel arrangement and being perpendicular to each other.
In one of the monomers, the palladium center (Pd1) is surrounded by the ortho aromatic carbon of the phenyl ring (C5), the imine nitrogen (N1) and two sulfur atoms (S1 and S2) exhibiting two different bonds with palladium: Pd−Schelate (S1) and Pd−Sbridging (S2).
As in the thiosemicarbazone ligand, an intramolecular interaction of ca. 2.5 Å (Figure 4) is observed between the fluorine atom and the imine methyl group. In this case, the aromatic ring is unable to rotate due to metallation, so the methyl group displays an eclipsed conformation.

2.1.3. Comparison between Bond Distances (Å) and Angles (°)

A comparative study of bond distances (Table 1) and angles (Table 2) between the thiosemicarbazone ligand 3a and the cyclometallated compound 4b was carried out.
The N(1)-C(7) and C(5)-C(6) bonds are somewhat longer in the cyclometallated compound due to the back-bonding of the palladium metal to the N(1) and the C(5) atoms, respectively.
The C(9)-N(2) and C(9)-S(1) bond differences are because of metallation; since it occurs in the thiolic form of the thiosemicarbazone, tautomerization of the C(9)=S(1) double bond is thus needed.
The C(9)-N(3) bond is slightly longer, probably due to the tautomerization of the thionic bond and the coordination of the sulfur atom.
The N(2)-C(9)-S(1), N(2)-C(9)-N(3) and N(3)-C(9)-S(1) angles change upon going to the cyclometallated compound due to the tautomerization and the coordination of the sulfur atom to palladium.
The C(5)-C(6)-C(7) and N(1)-N(2)-C(9) are smaller due to the formation of the five-membered chelate ring upon cyclometallation.

2.1.4. Palladium Bonds and Angles in Compound 4b

The bond distances with palladium are in accordance with those found in similar complexes [27,28,29] and angles with a square-planar geometry of the metal center (see Table 3).

3. Conclusions

  • X-ray structural analysis was carried out for a thiosemicarbazone ligand and its cyclometallated palladium derivative.
  • A comparative study allowed the determination of variations in bond distances and angles in the structure of the ligand after the cyclometallation process.
  • The metal atom displays the typical square-planar geometry for palladium.

Author Contributions

Conceptualization, M.R.-S. and P.M.-C.; methodology, M.R.-S.; software, M.R.-S.; validation, M.R.-S. and P.M.-C.; formal analysis, M.R.-S.; investigation, M.R.-S. and P.M.-C.; resources, J.M.O. and J.M.V.; data curation, M.R.-S. and P.M.-C.; writing—original draft preparation, M.R.-S.; writing—review and editing, M.R.-S.; visualization, M.R.-S. and P.M.-C.; supervision, J.M.O. and J.M.V.; project administration, M.R.-S. and J.M.V.; funding acquisition, J.M.O. and J.M.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Xunta de Galicia (Galicia, Spain) under the Grupos de Referencia program (GRC 2019/014).

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Crystal data and structure refinement for 3a.
Table A1. Crystal data and structure refinement for 3a.
Identification code3a
Empirical formulaC11H14FN3S
Formula weight239.31
Temperature100(2) K
Wavelength0.71073 Å
Crystal systemMonoclinic
Space groupP21/n
Unit cell dimensionsa = 5.8663(2) Å, α = 90°
b = 19.5573(6) Å, β = 105.0047(10)°.
c = 10.5485(3) Å, γ = 90°.
Volume1168.96(6) Å3
Z4
Density (calculated)1.360 Mg/m3
Absorption coefficient0.266 mm−1
F(000)504
Crystal size0.240 × 0.127 × 0.119 mm3
Theta range for data collection2.083 to 26.366°.
Index ranges−6 ≤ h ≤ 7, −24 ≤ k ≤ 24, −13 ≤ l ≤ 13
Reflections collected32894
Independent reflections2399 [R(int) = 0.0527]
Completeness to theta = 25.242°100.0%
Refinement methodFull-matrix least-squares on F2
Data/restraints/parameters2399/0/147
Goodness-of-fit on F21.050
Final R indices [I > 2sigma(I)]R1 = 0.0302, wR2 = 0.0712
R indices (all data)R1 = 0.0372, wR2 = 0.0751
Largest diff. peak and hole0.246 and −0.266 e·Å−3
Table A2. Crystal data and structure refinement for 4b.
Table A2. Crystal data and structure refinement for 4b.
Identification code4b
Empirical formulaC64H52Cl12F4N12Pd4S4
Formula weight2044.41
Temperature100(2) K
Wavelength0.71073 Å
Crystal systemTriclinic
Space groupP-1
Unit cell dimensionsa = 13.6814(4) Å, α = 87.1620(10)°
b = 15.1512(4) Å, β = 79.4790(10)°
c = 19.9092(5) Å, γ = 64.1110(10)°
Volume3648.25(17) Å3
Z2
Density (calculated)1.861 Mg/m3
Absorption coefficient1.585 mm−1
F(000)2016
Crystal size0.180 × 0.160 × 0.070 mm3
Theta range for data collection2.082 to 28.342°.
Index ranges−18 ≤ h ≤ 18, −20 ≤ k ≤ 20, −26 ≤ l ≤ 26
Reflections collected112138
Independent reflections18195 [R(int) = 0.0390]
Completeness to theta = 25.242°99.9%
Refinement methodFull-matrix least-squares on F2
Data/restraints/parameters18195/0/1020
Goodness-of-fit on F21.049
Final R indices [I>2sigma(I)]R1 = 0.0299, wR2 = 0.0625
R indices (all data)R1 = 0.0390, wR2 = 0.0666
Largest diff. peak and hole2.352 and −1.613 e·Å−3

References

  1. Abás, E.; Gómez-Bachiller, M.; Colom, E.; Pardina, E.; Rodríguez-Diéguez, A.; Grasa, L.; Laguna, M. Cyclometallated gold(III) complexes against colon cancer. X-ray structure of [Au(C,NPhenylpyridine)(OAc)2]. J. Organomet. Chem. 2020, 920, 121340. [Google Scholar] [CrossRef]
  2. Tong, X.; Zhang, L.; Li, L.; Li, Y.; Yang, Z.; Zhu, D.; Xie, Z. Water-soluble cyclometalated Ir (III) complexes as carrier-free and pure nanoparticle photosensitizers for photodynamic therapy and cell imaging. Dalton Trans. 2020, 49, 11493–11497. [Google Scholar] [CrossRef] [PubMed]
  3. Lobana, T.S.; Sharma, R.; Bawa, G.; Khanna, S. Bonding and structure trends of thiosemicarbazone derivatives of metals—An overview. Coord. Chem. Rev. 2009, 253, 977–1055. [Google Scholar] [CrossRef]
  4. Srishailam, K.; Ramaiah, K.; Reddy, K.L.; Reddy, B.V.; Rao, G.R. Synthesis and evaluation of molecular structure from torsional scans, study of molecular characteristics using spectroscopic and dft methods of some thiosemicarbazones, and investigation of their anticancer activity. Chem. Pap. 2021, 75, 3635–3647. [Google Scholar] [CrossRef]
  5. Mrozek-Wilczkiewicz, A.; Malarz, K.; Rejmund, M.; Polanski, J.; Musiol, R. Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety. Eur. J. Med. Chem. 2019, 171, 180–194. [Google Scholar] [CrossRef]
  6. Yousef, T.A.; Abu El-Reash, G.M. Synthesis, and biological evaluation of complexes based on thiosemicarbazone ligand. J. Mol. Struct. 2020, 1201, 127180. [Google Scholar] [CrossRef]
  7. Özerkan, D.; Ertik, O.; Kaya, B.; Kuruca, S.E.; Yanardag, R.; Ülküseven, B. Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition. Investig. New Drugs 2019, 37, 1187–1197. [Google Scholar] [CrossRef]
  8. Zaera, F. An organometallic guide to the chemistry of hydrocarbon moieties on transition metal surfaces. Chem. Rev. 1995, 95, 2651–2693. [Google Scholar] [CrossRef]
  9. Jain, V.K. Cyclometalated group-16 compounds of palladium and platinum: Challenges and opportunities. Coord. Chem. Rev. 2021, 427, 213546. [Google Scholar] [CrossRef]
  10. Munín-Cruz, P.; Reigosa, F.; Rúa-Sueiro, M.; Ortigueira, J.M.; Pereira, M.T.; Vila, J.M. Chemistry of tetradentate [C,N : C,N] iminophosphorane palladacycles: Preparation, reactivity and theoretical calculations. ChemistryOpen 2020, 9, 1190–1194. [Google Scholar] [CrossRef]
  11. Lucio-Martínez, F.; Bermúdez, B.; Ortigueira, J.M.; Adams, H.; Fernández, A.; Pereira, M.T.; Vila, J.M. A highly effective strategy for encapsulating potassium cations in small crown ether rings on a dinuclear palladium complex. Chem.—Eur. J. 2017, 23, 6255–6258. [Google Scholar] [CrossRef] [PubMed]
  12. Meng, K.; Li, T.; Yu, C.; Shen, C.; Zhang, J.; Zhong, G. Geminal group-directed olefinic CH functionalization via four-to eight-membered exo-metallocycles. Nat. Commun. 2019, 10, 5109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Liu, H.-J.; Ziegler, M.S.; Tilley, T.D. Synthesis, structures, and reactivity studies of cyclometalated N-heterocyclic carbene complexes of ruthenium. Dalton Trans. 2018, 47, 12138–12146. [Google Scholar] [CrossRef] [PubMed]
  14. Samiee, S.; Shiralinia, A.; Hoveizi, E.; Gable, R.W. A new family of oxime palladacycles mixed with unsymmetrical phosphorus ylides; synthesis, structural, cytotoxicity and catalytic activity studies. J. Organomet. Chem. 2019, 900, 120927. [Google Scholar] [CrossRef]
  15. Dharani, S.; Kalaiarasi, G.; Sindhuja, D.; Lynch, V.M.; Shankar, R.; Karvembu, R.; Prabhakaran, R. Tetranuclear palladacycles of 3-Acetyl-7-methoxy-2H-chromen-2-one derived Schiff Bases: Efficient catalysts for Suzuki–Miyaura coupling in an aqueous medium. Inorg. Chem. 2019, 58, 8045–8055. [Google Scholar] [CrossRef]
  16. López-Mosquera, C.; Grabulosa, A.; Rocamora, M.; Font-Bardia, M.; Muller, G. Cyclopalladated compounds with polyhalogenated benzylphosphanes for the Mizoroki-Heck reaction. Eur. J. Inorg. Chem. 2020, 2020, 2470–2484. [Google Scholar] [CrossRef]
  17. Maji, A.; Singh, O.; Singh, S.; Mohanty, A.; Maji, P.K.; Ghosh, K. Palladium-based catalysts supported by unsymmetrical XYC–1 type pincer ligands: C5 arylation of imidazoles and synthesis of octinoxate utilizing the Mizoroki–Heck reaction. Eur. J. Inorg. Chem. 2020, 2020, 1596–1611. [Google Scholar] [CrossRef]
  18. Serrano, J.L.; Girase, T.R. Palladacycles as efficient precatalysts for Negishi and Buchwald-Hartwig amination reactions. In Palladacycles; Elsevier: Amsterdam, The Netherlands, 2019; pp. 175–224. [Google Scholar]
  19. Yu, F.; Shen, W.; Sun, Y.; Liao, Y.; Jin, S.; Lu, X.; He, R.; Zhong, L.; Zhong, G.; Zhang, J. Ruthenium-catalyzed C-H amination of aroylsilanes. Org. Biomol. Chem. 2021, 19, 6313–6321. [Google Scholar] [CrossRef]
  20. Pike, S.; Lord, R.; Kergreis, A. Influence of ligand and nuclearity on the cytotoxicity of cyclometallated C^N^C platinum (II) complexes. Chem.—Eur. J. 2020, 26, 14938–14946. [Google Scholar]
  21. Oliveira, C.G.; Romero-Canelón, I.; Coverdale, J.P.; Maia, P.I.S.; Clarkson, G.J.; Deflon, V.M.; Sadler, P.J. Novel tetranuclear Pd II and Pt II anticancer complexes derived from pyrene thiosemicarbazones. Dalton Trans. 2020, 49, 9595–9604. [Google Scholar] [CrossRef]
  22. Licona, C.; Delhorme, J.-B.; Riegel, G.; Vidimar, V.; Cerón-Camacho, R.; Boff, B.; Venkatasamy, A.; Tomasetto, C.; Gomes, P.d.S.F.C.; Rognan, D. Anticancer activity of ruthenium and osmium cyclometalated compounds: Identification of ABCB1 and EGFR as resistance mechanisms. Inorg. Chem. Front. 2020, 7, 678–688. [Google Scholar] [CrossRef]
  23. Williams, M.R.; Bertrand, B.; Hughes, D.L.; Waller, Z.A.; Schmidt, C.; Ott, I.; O’Connell, M.; Searcey, M.; Bochmann, M. Cyclometallated Au (III) dithiocarbamate complexes: Synthesis, anticancer evaluation and mechanistic studies. Metallomics 2018, 10, 1655–1666. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Rúa Sueiro, M.; Ortigueira, J.M.; Vila, J.M. Cyclometallated thiosemicarbazones containing fluorine atoms: A solubility improvement. In Proceedings of the 25th International Electronic Conference on Synthetic Organic Chemistry; MDPI: Basel, Switzerland, 2021. [Google Scholar]
  25. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.; Puschmann, H. Olex2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  26. Casas, J.; Garcıa-Tasende, M.; Sordo, J. Main group metal complexes of semicarbazones and thiosemicarbazones. A structural review. Coord. Chem. Rev. 2000, 209, 197–261. [Google Scholar] [CrossRef]
  27. Rúa-Sueiro, M.; Munín-Cruz, P.; Reigosa, F.; Vila, J.M.; Ortigueira, J.M. Synthesis and X-Ray diffraction study of thiosemicarbazone palladacycles with dppm. Proceedings 2020, 62, 13. [Google Scholar]
  28. Martínez, J.; Cabaleiro-Lago, E.M.; Ortigueira, J.M.; Pereira, M.T.; Frieiro, P.; Lucio, F.; Vila, J.M. Synthesis and reactivity of thiosemicarbazone palladacycles. Crystal structure analysis and theoretical calculations. Inorg. Chim. Acta 2016, 449, 20–30. [Google Scholar] [CrossRef]
  29. Pereira, M.T.; Antelo, J.M.; Adrio, L.A.; Martinez, J.; Ortigueira, J.M.; Lopez-Torres, M.; Vila, J.M. Novel bidentate [N,S] palladacycle metalloligands. 1H-15N HMBC as a decisive NMR technique for the structural characterization of Palladium-Rhodium and Palladium-Palladium bimetallic complexes. Organometallics 2014, 33, 3265–3274. [Google Scholar] [CrossRef]
Scheme 1. Reaction sequence leading to the synthesis of cyclometallated complexes containing fluor atoms.
Scheme 1. Reaction sequence leading to the synthesis of cyclometallated complexes containing fluor atoms.
Chemproc 09 00003 sch001
Scheme 2. Compounds 3a and 4b were studied by X-ray diffraction study.
Scheme 2. Compounds 3a and 4b were studied by X-ray diffraction study.
Chemproc 09 00003 sch002
Figure 1. Molecular structure of ligand 3a. Thermal ellipsoids are shown at 50% probability level.
Figure 1. Molecular structure of ligand 3a. Thermal ellipsoids are shown at 50% probability level.
Chemproc 09 00003 g001
Figure 2. (a) Intramolecular interactions between F(1)-H and N(1)-H. (b) Deviation of the phenyl ring from the thiosemicarbazone plane.
Figure 2. (a) Intramolecular interactions between F(1)-H and N(1)-H. (b) Deviation of the phenyl ring from the thiosemicarbazone plane.
Chemproc 09 00003 g002
Figure 3. (a) Molecular structure of a monomer of 4b. Thermal ellipsoids are shown at 50% probability level. (b) Molecular structure of 4b, with antiparallel and perpendicular arrangement of each thiosemicarbazone.
Figure 3. (a) Molecular structure of a monomer of 4b. Thermal ellipsoids are shown at 50% probability level. (b) Molecular structure of 4b, with antiparallel and perpendicular arrangement of each thiosemicarbazone.
Chemproc 09 00003 g003
Figure 4. Intramolecular interaction of F(1)-H in compound 4b.
Figure 4. Intramolecular interaction of F(1)-H in compound 4b.
Chemproc 09 00003 g004
Table 1. Comparison between bonds in compounds 3a and 4b.
Table 1. Comparison between bonds in compounds 3a and 4b.
Bond3a/Å4b/Å
N(1)-C(7)1.2870(18)1.304(3)
C(9)-N(2)1.3677(18)1.297(3)
C(9)-S(1)1.6816(14)1.807(3)
C(9)-N(3)1.3297(18)1.361(3)
C(5)-C(6)1.399(2)1.424(4)
Table 2. Comparison between angles in compounds 3a and 4b.
Table 2. Comparison between angles in compounds 3a and 4b.
Angle3a/°4b/°
C(5)-C(6)-C(7)121.14(12)116.3(2)
N(1)-N(2)-C(9)117.90(11)114.1(2)
N(2)-C(9)-S(1)119.57(11)125.16(19)
N(2)-C(9)-N(3)115.62(12)120.6(2)
N(3)-C(9)-S(1)124.81(11)114.08(18)
Table 3. Distance bonds (Å) and angles (°) around palladium metal center.
Table 3. Distance bonds (Å) and angles (°) around palladium metal center.
BondAngle
Pd(1)-N(1)1.996(2)N(1)-Pd(1)-C(5)81.24(9)
Pd(1)-C(5)2.003(2)N(1)-Pd(1)-S(1)83.31(6)
Pd(1)-S(2)2.3060(6)C(5)-Pd(1)-S(2)94.39(8)
Pd(1)-S(1)2.3729(6)S(2)-Pd(1)-S(1)100.81(2)
N(1)-Pd(1)-S(2)174.68(6)
C(5)-Pd(1)-S(1)164.07(8)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rúa-Sueiro, M.; Munín-Cruz, P.; Ortigueira, J.M.; Vila, J.M. X-ray Diffraction Study of Fluorine-Functionalized Thiosemicarbazones and Cyclometallated Compounds. Chem. Proc. 2022, 9, 3. https://doi.org/10.3390/IOCC_2022-12140

AMA Style

Rúa-Sueiro M, Munín-Cruz P, Ortigueira JM, Vila JM. X-ray Diffraction Study of Fluorine-Functionalized Thiosemicarbazones and Cyclometallated Compounds. Chemistry Proceedings. 2022; 9(1):3. https://doi.org/10.3390/IOCC_2022-12140

Chicago/Turabian Style

Rúa-Sueiro, Marcos, Paula Munín-Cruz, Juan M. Ortigueira, and José M. Vila. 2022. "X-ray Diffraction Study of Fluorine-Functionalized Thiosemicarbazones and Cyclometallated Compounds" Chemistry Proceedings 9, no. 1: 3. https://doi.org/10.3390/IOCC_2022-12140

APA Style

Rúa-Sueiro, M., Munín-Cruz, P., Ortigueira, J. M., & Vila, J. M. (2022). X-ray Diffraction Study of Fluorine-Functionalized Thiosemicarbazones and Cyclometallated Compounds. Chemistry Proceedings, 9(1), 3. https://doi.org/10.3390/IOCC_2022-12140

Article Metrics

Back to TopTop